Operating Lease, Right-of-Use Asset of Werewolf Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Werewolf Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Werewolf Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $5,422,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Werewolf Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,422,000 -$756,000 -12% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $5,620,000 -$727,000 -11% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $5,813,000 -$699,000 -11% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $6,001,000 -$887,000 -13% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $6,178,000 -$1,073,000 -15% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,347,000 -$1,441,000 -19% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $6,512,000 -$1,615,000 -20% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $6,888,000 -$1,575,000 -19% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $7,251,000 -$1,353,000 -16% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $7,788,000 -$1,282,000 -14% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $8,127,000 -$3,077,000 -27% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $8,463,000 -$4,949,000 -37% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $8,604,000 +$6,641,000 +338% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $9,070,000 +$6,935,000 +325% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $11,204,000 +$8,899,000 +386% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $13,412,000 +$10,941,000 +443% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $1,963,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $2,135,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $2,305,000 31 Mar 2021 10-Q 10 Jun 2021 2021 Q1
Q4 2020 $2,471,000 31 Dec 2020 10-K 24 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.